B-XPANDER
Live / Applied — Second extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 15 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98501005
- Mark type
- Stylized text
- Filed
- 15 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Benjamin Taggart
Goods and services
- Class 001 — Chemicals: Biochemical proteins for scientific, pre-clinical, and clinical research; Biochemical proteins for use in translational in vivo research; Biochemical proteins for use in immunotherapeutic research; Biochemical proteins for use in medical research; Bioreagents for scientific, pre-clinical, and clinical research; Bioreagents for use in translational in vivo research; Bioreagents for use in immunotherapeutic research; Bioreagents for use in medical research
Owner
- Adipogen Life Sciences, Inc., San Diego, CA, US
- Adipogen Life Sciences, Inc., San Diego, CA, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 24 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 08 Jan 2026 — PETITION TO REVIVE-GRANTED
- 08 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 1 GRANTED
- 07 Jul 2025 — SOU EXTENSION 1 FILED
- 07 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION